Search Results 1441-1450 of 15613 for circadian rhythms

  1. Establishment of a Biorepository of Baseline and Follow-up Saliva Samples Collected from Newly Diagnosed, Treatment-naïve Cancer Patients - Mayo Clinic

    About this study. The ultimate goal of this biobank will be to provide the resource to initiate an exploration of human saliva as a potential liquid biopsy ...

  2. Publications

    Publications. Kakar S, Dittman LE, Rozenits A, Kalapos R. Over-the-Top Foveal Triangular Fibrocartilage Complex Repair. J Hand Surg Am. 2024 Nov; ...

  3. Neurology - Clinical trials - Mayo Clinic

    Each biological child of a person with an ADAD mutation has a 50% risk of inheriting the mutation, and thus of developing ADAD. This study will develop a ...

  4. Study Treating Patients with Relapsed or Refractory Aggressive B-cell Lymphomas Using Nivolumab with or without Varlilumab - Mayo Clinic

    ... biological or physiological causes; in addition, females under the age of 55 must have a documented serum follicle stimulating hormone (FSH) level less than ...

  5. Faculty - Center for Individualized Medicine - Mayo Clinic Research

    El Melik, Razan M. Pharm.D., R.Ph. ElMelik.Razan@mayo.edu; Assistant Professor of Pharmacy. More about research at Mayo Clinic.

  6. Genome Maintenance and Chromatin Plasticity in Cancer: Arvind Panday - Mayo Clinic Research

    However, many people who have cancer that's linked to the BRCA gene don't respond to PARP inhibitors. Therefore, there is a pressing need to find new treatments ...

  7. Joao Passos, Ph.D. - Mayo Clinic Faculty Profiles

    Passos' current work is to develop new therapies that target mitochondrial dysfunction to counteract the detrimental impact of senescent cells with aging and ...

  8. Extended and Mobile Clinical Research and Trials Unit (CRTU) - Center for Clinical and Translational Science

    Specially trained research nurses and support staff conduct protocols, secure specimens, administer medications and gather critical data at the bedside of ...

  9. A Randomized Phase 3 Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients with Advanced Angiosarcoma (TAPPAS) - Mayo Clinic

    About this study. This is a study of TRC105 in combination with standard dose pazopanib compared to single agent pazopanib in patients with angiosarcoma not ...

  10. A Study to Evaluate Rivaroxaban to Reduce Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients with Acute COVID-19 Infection - Mayo Clinic

    The purpose of this study is to investigate the effectiveness and safety of Rivaroxaban for reducing the risk of major venous and arterial thrombotic events, ...